Journal article
Consensus recommendations on the use of F-FDG PET/CT in lung disease
Journal of Nuclear Medicine, Vol.61(12), pp.1701-1707
12/01/2020
DOI: 10.2967/jnumed.120.244780
PMCID: PMC9364897
PMID: 32948678
Abstract
PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to study drug effects and pulmonary biology and to monitor disease progression and treatment outcomes in lung diseases that interfere with gas exchange through alterations of the pulmonary parenchyma, airways, or vasculature. To date, however, there are no widely accepted standard acquisition protocols or imaging data analysis methods for pulmonary 18F-FDG PET/CT in these diseases, resulting in disparate approaches. Hence, comparison of data across the literature is challenging. To help harmonize the acquisition and analysis and promote reproducibility, we collated details of acquisition protocols and analysis methods from 7 PET centers. From this information and our discussions, we reached the consensus recommendations given here on patient preparation, choice of dynamic versus static imaging, image reconstruction, and image analysis reporting.
Details
- Title: Subtitle
- Consensus recommendations on the use of F-FDG PET/CT in lung disease
- Creators
- Delphine L. Chen - University of WashingtonSafia Ballout - University of LeedsLaigao Chen - Pfizer (United States)Joseph Cheriyan - Cambridge University Hospitals NHS Foundation TrustGourab Choudhury - University of EdinburghAna M. Denis-Bacelar - National Physical LaboratoryElise Emond - University College LondonKjell Erlandsson - University College LondonMarie Fisk - University of CambridgeFrancesco Fraioli - University College LondonAshley M. Groves - University College LondonRoger N. Gunn - Imperial College LondonJun Hatazawa - The University of OsakaBeverley F. Holman - University College LondonBrian F. Hutton - University College LondonHidehiro Iida - University of TurkuSarah Lee - Amallis Consulting Ltd., London, United KingdomWilliam MacNee - The Queen's Medical Research InstituteKeiko Matsunaga - The University of OsakaDivya Mohan - GlaxoSmithKline (United States)David Parr - University Hospitals Coventry and Warwickshire NHS TrustAlaleh Rashidnasab - University College LondonGaia Rizzo - Imperial College LondonDeepak Subramanian - Derby Teaching Hospitals, NHS Foundation Trust, Derby, United KingdomRuth Tal-Singer - GlaxoSmithKline (United States)Kris Thielemans - University College LondonNicola Tregay - University of CambridgeEdwin J.R. van Beek - University of EdinburghLaurence Vass - University of CambridgeMarcos F. Vidal Melo - Harvard Medical SchoolJeremy W. Wellen - Research and Early Development, Celgene, Cambridge, MA, United StatesIan Wilkinson - University of CambridgeFrederick J. Wilson - GlaxoSmithKline (United Kingdom)Tilo Winkler - Massachusetts General Hospital
- Resource Type
- Journal article
- Publication Details
- Journal of Nuclear Medicine, Vol.61(12), pp.1701-1707
- DOI
- 10.2967/jnumed.120.244780
- PMID
- 32948678
- PMCID
- PMC9364897
- NLM abbreviation
- J Nucl Med
- ISSN
- 0161-5505
- eISSN
- 2159-662X
- Publisher
- SOC NUCLEAR MEDICINE INC
- Grant note
- R01HL131908 / National Heart, Lung, and Blood Institute (http://data.elsevier.com/vocabulary/SciValFunders/100000050) Siemens Medical Solutions USA (http://data.elsevier.com/vocabulary/SciValFunders/100015696) SINAPSE GlaxoSmithKline (http://data.elsevier.com/vocabulary/SciValFunders/100004330) Cambridge NIHR Comprehensive Biomedical Research Centre P41 EB025815; R01 HL121218 / National Institutes of Health (http://data.elsevier.com/vocabulary/SciValFunders/100000002) GE Healthcare (http://data.elsevier.com/vocabulary/SciValFunders/100006775) RO1 HL121228 / NIH-NHLBI Engineering and Physical Sciences Research Council (http://data.elsevier.com/vocabulary/SciValFunders/501100000266) Scottish Imaging Network
- Language
- English
- Date published
- 12/01/2020
- Academic Unit
- Anesthesia
- Record Identifier
- 9985142950502771
Metrics
1 Record Views